Results 151 to 160 of about 2,002,341 (191)

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis [PDF]

European Journal of Surgical Oncology, 2015
Radioembolization with yttrium-90 microspheres offers an alternative treatment option for patients with unresectable intrahepatic cholangiocarcinoma (ICC).
Norman Kneteman
exaly   +3 more sources

Radioembolization of Yttrium-90 Microspheres for Hepatic Malignancy [PDF]

Seminars in Interventional Radiology, 2008
The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of ...
Riad Salem, Ravi Murthy
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Yttrium-90 Radioembolization: Current Indications and Outcomes

Journal of Gastrointestinal Surgery, 2023
Radioembolization (RE) with 90Yttrium (Y90) has generally been used to treat patients with advanced disease. Recent data suggest, however, that RE is also safe and feasible to treat patients with early or intermediate stage disease. We herein review the current evidence regarding the use of RE with Y90 for patients with HCC.A comprehensive review of ...
Ahmad Hamad, Hassan Aziz, Ihab R. Kamel, Dayssy Alexandra Diaz, Timothy M. Pawlik   +4 more
openaire   +2 more sources

Abscopal Effects and Yttrium-90 Radioembolization

CardioVascular and Interventional Radiology, 2015
We present the case of an 80-year-old male with squamous cell carcinoma with bilobar hepatic metastases who underwent targeted Yttrium-90 radioembolization of the right hepatic lobe lesion. Subsequently, there was complete regression of the nontargeted, left hepatic lobe lesion.
Anish, Ghodadra, Sumantha, Bhatt, Juan C, Camacho, Hyun S, Kim   +3 more
openaire   +2 more sources

Yttrium-90 Radioembolization for Hepatocellular Carcinoma

Seminars in Nuclear Medicine, 2016
(90)Y radioembolization refers to the selective, transcatheter, and intra-arterial injection of micrometer-sized particles loaded with the radioisotope yttrium-90 for the treatment of primary and metastatic hepatic malignancies. In the treatment of intermediate- and advanced-stage hepatocellular carcinoma, (90)Y radioembolization provides favorable ...
Ryan M, Hickey, Robert J, Lewandowski, Riad, Salem   +2 more
openaire   +2 more sources

Safety of Repeated Yttrium-90 Radioembolization

CardioVascular and Interventional Radiology, 2013
Repeated radioembolization (RE) treatments carry theoretically higher risk of radiation-induced hepatic injury because of the liver's cumulative memory of previous exposure. We performed a retrospective safety analysis on patients who underwent repeated RE.From 2004 to 2011, a total of 247 patients were treated by RE.
Marnix G E H, Lam, John D, Louie, Andrei H, Iagaru, Michael L, Goris, Daniel Y, Sze   +4 more
openaire   +2 more sources

Yttrium-90 Radioembolization in the Office-Based Lab

Journal of Vascular and Interventional Radiology, 2020
To evaluate the feasibility and benefits of performing yttrium-90 radioembolization in an office-based lab (OBL) compared to a hospital setting.A radioembolization program was established in March 2019 in an OBL that is managed by the radiology department of a tertiary care center.
Ryan M, Hickey, John M, Maslowski, Eric T, Aaltonen, Jeremy Cash, Horn, Amish, Patel, Akhilesh K, Sista, Jonathan S, Gross   +6 more
openaire   +2 more sources

Yttrium-90 Radioembolization in the Management of Liver Malignancies

Seminars in Oncology, 2010
Primary and secondary liver tumors are common. Locoregional therapies are establishing a role in the management of liver tumors due to the limited roles of surgical and systemic therapies. Our review presents some general concepts associated with yttrium-90 radioembolization and its specific utilization in various primary and secondary liver ...
Ahsun, Riaz, Laura M, Kulik, Mary F, Mulcahy, Robert J, Lewandowski, Riad, Salem   +4 more
openaire   +2 more sources

Radioembolization of Liver Tumors With Yttrium-90 Microspheres

Seminars in Nuclear Medicine, 2010
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing evidence for efficiency in liver tumors of various entities, with the most prominent ones being hepatocellular carcinoma, colorectal cancer, and ...
Hojjat, Ahmadzadehfar, Hans-Jürgen, Biersack, Samer, Ezziddin   +2 more
openaire   +2 more sources

Biliary Sequelae following Radioembolization with Yttrium-90 Microspheres

Journal of Vascular and Interventional Radiology, 2008
Yttrium-90 (90Y) radioembolization has emerged as a promising and safe therapeutic modality for patients with hepatocellular carcinoma (HCC) or metastatic liver cancer. The present report describes biliary sequelae following intraarterial 90Y therapy in patients with HCC or liver metastases.All patients were treated with 90Y therapy according to ...
Bassel, Atassi, Affaan K, Bangash, Robert J, Lewandowski, Saad, Ibrahim, Laura, Kulik, Mary F, Mulcahy, Ravi, Murthy, Robert K, Ryu, Kent T, Sato, Frank H, Miller, Reed A, Omary, Riad, Salem   +11 more
openaire   +2 more sources